Objective: Transcatheter aortic valve replacement is established therapy for highrisk and inoperable patients with severe aortic stenosis, but questions remain regarding long-term durability. Valve design influences durability. Increased leaflet stresses in surgical bioprostheses have been correlated with degeneration; however, transcatheter valve leaflet stresses are unknown. From 2007 to 2014, a majority of US patients received first-generation balloon-expandable transcatheter valves. Our goal was to determine stent and leaflet stresses in this valve design using finite element analyses.
See Editorial Commentary page 1074.
Transcatheter aortic valve replacement (TAVR) was first performed in a human of prohibitive surgical risk in 2002 using a balloon-expandable stainless steel stent with equine pericardial leaflets; specifically, the Cribier-Edwards (Edwards Lifesciences, Inc, Irvine, Calif) transcatheter aortic valve (TAV). 1 Subsequently, equine leaflets were replaced with bovine pericardium and the first-generation Edwards Sapien valve (Edwards Lifesciences, Inc) was created. This first-generation TAV was used in the pivotal Placement of Aortic Transcatheter Valves (PARTNER) randomized trials in the United States comparing TAVR to medical therapy in inoperable patients and comparing TAVR to surgical aortic valve replacement in high-risk patients beginning in April 2007. 2, 3 TAVR was superior to medical therapy 4, 5 for severe aortic stenosis in inoperable patients and equivalent to surgery in high-risk patients. 6 The secondgeneration TAV, Edwards Sapien XT (Edwards Lifesciences, Inc), modified the design to reduce stent profile using cobalt-chromium, and changed its leaflet design from an open to a semiclosed position. Sapien XT was approved for commercial use in June 2014; thus, presently in the United States, thousands of patients have had the original Sapien TAV implanted.
Because TAVR demonstrated equipoise with surgery in intermediate-risk patients 7 and will proceed to lower-risk surgical patients, a major concern is TAV long-term durability. Durability in surgical bioprostheses has been extensively studied. [8] [9] [10] Pathologically, bioprosthetic degeneration involves leaflet cusp calcification and stiffening, and leaflet tearing. Areas of increased stresses correlate with regions of calcific degeneration or leaflet tearing. 11, 12 Understanding TAV leaflet stresses is the first step toward understanding TAV durability and the regions prone to degeneration. Presently, TAV leaflet stresses are unknown and cannot be directly measured, but can be determined through finite element analyses (FEAs). FEA is an essential method to obtain valuable data about complicated real-world systems that would otherwise be impossible to directly measure. FEA when applied to medical device designs can be used to calculate stresses and investigate potential failure modes and locations. Finite element (FE) models require accurate 3-dimensional (3D) geometry in the zero-stress state, material properties, and physiologic loading conditions. Our goal was to determine stent and leaflet stresses in the firstgeneration 26-mm Edwards Sapien TAV (Edwards Lifesciences, Inc), which was implanted during the PARTNER trial and received initial TAVR commercialization in the United States. In addition, noncylindrical TAV shape after implantation in the calcified aortic root has been observed, which can cause moderate postoperative paravalvular regurgitation. 13 A distorted implanted TAV may experience higher stress levels. 14 
MATERIALS AND METHODS
We obtained a commercial 26-mm Edwards Sapien valve (external diameter, 26 mm and height, 16.1 mm) that consisted of 3 components: stainless steel stent, polyethylene terephthalate covering, and bovine pericardial leaflets. Physical measurements were taken and the suture connections between different components were studied to enable accurate modeling of the valve. The process to determine TAV stress distribution included micro-computed tomography (micro-CT) scanning of the 26-mm Sapien valve at 0 mm Hg; development of TAV mesh using 3D geometry of the leaflets, stent, and polyethylene terephthalate; application of material properties of the stent and leaflets followed by systemic pressure loading; and FEA using a finite element (FE) solver.
Sapien TAV Mesh Generation
A fully expanded Sapien valve (26 mm) was imaged under 0 mm Hg pressure with a desktop cone-beam micro-CT scanner (microCT-40; Scanco Medical AG, Baseldorf, Switzerland) in different orientations and intensities to distinguish stent and leaflet geometries. Scan settings used were: 45kVp for x-ray energy, 200 mA for x-ray current, 0.5 mm aluminum filter, 50 mm field of view, 50 mm voxel size, and 200 ms integration time. Highresolution Digital Imaging and Communications in Medicine radiologic images (voxel size, 50 3 50 3 50 mm) were imported into MeVisLab, an open source surface reconstruction software (http://www.mevislab.de/). Digital Imaging and Communications in Medicine files were scanned individually to separate TAV stent versus leaflets materials to obtain the most accurate representation of their respective geometries. Stent and leaflet surfaces were combined using suture lines as a reference point for leaflet orientation. The reconstructed surface was then imported into GeoMagic Design, (3DSystems, Rock Hill, SC), a computer-aided design software, to refine and create the 3D geometric volume with accurate size and thickness at zero stress. The refined geometries of leaflets, stent, and polyethylene terephthalate were then imported into HyperMesh (Altair Engineering, Troy, Mich) to generate TAV mesh with 46,443 total elements.
Constitutive Model and Material Properties
TAV stent and leaflets were assigned material properties. Sapien valves use leaflets made of specially treated bovine pericardium to resist calcification and that proprietary process was the same as for corresponding surgical Carpentier-Edwards Magna pericardial valves (Edwards Lifesciences, Inc). Biaxial stretch testing of these surgical valves was performed to determine material properties of TAV leaflets to avoid destroying the leaflets of the 26-mm Sapien. Methods of biaxial stretching have been previously described. 13 TAV leaflets were assumed to be anisotropic, nonlinear, hyperelastic, and orthotropic materials. The material's response to stress was described mathematically by a set of constitutive equations derived from strain energy function W. Using Fung-type hyperelastic material, W was described as
where c, c i , and D are material parameters; E jk and E lm are quadratic form of Green-Lagrangian strain; and J is the determinant of deformation tensor.
Abbreviations and Acronyms
Material parameters in the above equations are obtained from biaxial tensile tests previously conducted in our laboratory (listed in Table 1 ). Stainless steel material properties were used for the stent and it was modeled using an elastic-plastic material with Young's modulus, Poisson's ratio, yield stress, and hardening parameters as material constants (Table 1) .
FE Simulation
FE simulations were performed using the commercial FE solver, ABA-QUS (Dassault Syst ems, Waltham, Mass). Stent geometry was modeled using 3D brick elements, whereas leaflet geometry was modeled using nonlinear shell elements. Mesh sizes chosen for the stent and leaflets were 0.5 and 0.25 mm, respectively. Contact definitions between the leaflets and between leaflet and stent were investigated to choose one most accurately representing the overall behavior. Leaflet nodes were connected to the stent using a TIE contact (coefficient of friction value, 0.1). TAV leaflet geometries were sutured to the polyethylene terephthalate mesh at the bottom ( Figure 1 ) and tied to stent geometry at the top. The TAV leaflet mesh was subdivided into 3 distinct regions (Figure 1 , A) to study stress distribution due to pressure loading on the sutured edges, upper free edge region, and lower belly region.
To simulate elliptical shape of TAV after deployment based on clinical post-TAVR patient computed tomography data on Sapien valves, 15 additional displacement was applied to specified portions of the stent. The outline of the stent and sutured leaflets were deployed to noncylindrical shape with nonuniform radial distances. After deployment, simulations were performed to determine TAV stresses based on arterial pressure on a manufactured TAV without crimping and balloon expansion. Nondistorted and distorted TAV stent and leaflets were exposed to systemic pressure of 80 mm Hg and 120 mm Hg using quasistatic pressure loading. Boundary conditions were applied to the TAV stent to prevent any rigid body motion. The longitudinal displacement of the 9 proximal nodes of the stent were constrained to represent TAV deployment into diseased native valves.
RESULTS
The 26-mm Sapien valve geometry, including TAV leaflets, the stent, and the polyethylene terephthalate elements, were precisely reconstructed and aligned. Leaflets were attached to polyethylene terephthalate and the stent along suture lines. Data presented here were from a single optimized simulation after mesh refinement studies, adjusting the material parameters and boundary conditions. The geometry of the 26-mm Sapien valve and corresponding FE mesh are shown in Figure 1 . Loading and boundary conditions were applied to stent and leaflet assembly. Maximum and minimum principal stresses for entire leaflet assembly and each subregion, are shown for 80 mm Hg and 120 mm Hg (using quasistatic loading condition) in Figure 2 . High stress concentration locations were determined. Maximum principal stresses across entire leaflet, including sutured regions, at 80 and 120 mm Hg, were 2.54 and 3.06 megapascal (MPa), respectively ( Figure 3, I and K) . Minimum principal stresses across the entire leaflet, including sutured regions, at 80 and 120 mm Hg, were À0.78 and À1.08 MPa, respectively ( Figure 3, J and L) . Positive stress values correspond to tensile stress where TAV leaflets stretched to close, whereas negative stress values represent leaflet compression or bending where redundant tissue was compressed to close. Stress contours for each region are shown in Figure 3 .
Region 3 (sutured edges) contained the maximum and minimum principal stresses for the entire leaflet assembly (Figure 3, I-L) . Peak stress occurred at tips of leaflet commissures along the attachment with the stent (Figure 2) . In contrast, regions of free leaflet margin at the top and leaflet belly at the bottom had much lower peak stresses. principal stresses, and stress was evenly distributed in the area of leaflet belly (Figure 3, E-H) . Comparison of principal stresses for each leaflet region is plotted (Figure 4) . The maximum principal stress of the TAV at diastolic pressure is presented online (Video 1).
For this TAV stent, maximum principal stresses at 80 and 120 mm Hg were 188.91 and 251.98 MPa, respectively. Minimum principal stresses at 80 and 120 mm Hg were À258.49 and À362.99 MPa, respectively ( Figure 5 ). Peak stresses occurred where longitudinal motion was constrained, at the proximal deployment in the annulus, and where the leaflets were attached to stent/commissural posts. Maximum stress was present on the outside surface, whereas minimum stress was present on the inner surface.
The distorted noncylindrical TAV had an eccentricity of 0.127 (minimum diameter/maximum diameter). It is the largest eccentricity reported by a post-TAVR clinical study of Sapien valves. 15 For the distorted leaflets, upper free leaflet edges had maximum principal stress of 1.52 MPa (Figure 6 , A) and minimum principal stress of À0.36 MPa at 80 mm Hg. The peak stress was located at the commissures where leaflets were attached to the stent, similar to that of cylindrical geometry. The lower leaflet belly had a maximum principal stress of 0.83 MPa and minimum principal stress of À0.36 MPa at 80 mm Hg. The stent had maximum principal stress of 178.29 MPa (Figure 6 , B) and minimum principal stress of À244.39 MPa at 80 mm Hg.
DISCUSSION
From the initiation of the PARTNER trial in 2007 to commercialization of the Edwards Sapien XT in 2014, the majority of patients in the United States received a firstgeneration Sapien TAV. However, the long-term durability of this valve design or its subsequent iterations is unknown. The 5-year outcomes of the PARTNER trial revealed no structural valve dysfunction with maintenance of low gradients and increased valve area. 16 Short-term durability thus appears adequate, but much longer-term follow-up is required. The Sapien valve was designed using bovine pericardium treated by the same anticalcification processes as the surgical Carpentier-Edwards aortic pericardial valves. 17 Due to the size constraints of TAVR 22 Fr and 24 Fr delivery systems, TAV leaflets need to be thinner than surgical bioprostheses. Indeed, reduction further to 18 Fr then 14 Fr delivery systems for the Sapien XT and the third-generation Sapien 3 (Edwards Lifesciences, Inc), respectively, required altering stent material to cobalt-chromium and thinner leaflets to achieve a lower crimped TAV profile. Thinner leaflets translate into higher leaflet stresses unless compensated for by improvements in valve design. Leaflet stresses cannot be measured, but require FE modeling to determine. Accurate FE models require precise 3D geometry in a zero-stress state, material properties, and physiologic loading conditions. Previous FEA studies have attempted to determine TAV leaflet stresses using a generic estimated leaflet geometry based on surgical valves and homemade TAVs. 18, 19 However, exact TAV-particularly leaflet-geometry was not used. On the other hand, patient-specific FEA simulations have used exact TAV stent geometry to investigate the interaction of TAV stent with surrounding aortic root geometry, but did not focus on precise TAV leaflet geometry and thereby stresses. [20] [21] [22] Our study focused on FEA of TAV stresses using high-resolution micro-CT imaging of a Sapien valve to obtain accurate 3D geometry at nominal dimensions as a benchmark for comparison with future generations of TAVs or surgical valves.
In this study, we demonstrated that maximum and minimum principal stresses in 26-mm Sapien valves occurred proximally in the annulus, where the stent was deployed and confined. Overall, maximum and minimum principal stresses occurred where TAV leaflets were attached to the stent at the commissures. For the flexible regions of TAV leaflets, peak stresses were in the upper, V-shaped area approaching the commissure at systolic pressure. These regions of peak stress or locally higher stresses would be areas most prone to initiating degeneration. Relative durability of TAVR compared with surgical bioprostheses clinically is unknown. In studies of surgical bioprostheses, degeneration by calcification or leaflet tearing correlated with areas of high tensile and compressive stresses 23 as well as cyclic flexural fatigue and bending. 12 Sacks and colleagues 11 performed FEA of 2 Edwards Lifesciences Inc bovine pericardial valves under 120 mm Hg quasistatic loading conditions, with leaflet material properties determined from those valves and exact valve geometry. 11 Depending on which leaflet material properties were used, maximum in-plane stress ranged from 544.7 kilopascals (kPa) to 663.2 kPa. Leaflet stresses were greatest near the commissures and least near the free edge. Based on subsequent studies, their study used a 25-mm surgical bioprosthesis, which is the most similar in size to our 26-mm Sapien valve. Leaflet attachment to the stent can influence leaflet stress and their study attached the leaflets to the wire frame of the surgical bioprosthesis. In our study, maximum principal stress for a 26-mm Sapien valve was significantly higher than that reported for a surgical bioprosthesis, which may reflect differences in leaflet design or leaflet interaction with their respective frames. Chandran and colleagues 24 performed a dynamic FEA simulation with physiologic arterial pressures of a 23-mm bovine pericardial Edwards bioprosthesis. 24 They demonstrated peak von Mises stress of 2.09 MPa located at the cuspal commissures in the fully closed position. Peak stresses increased significantly with dynamic leaflet motion. Our simulation yielded higher peak von Mises stresses of 3.72 MPa in the quasistatic condition. Direct comparisons with results from the study by Chandran and colleagues 24 are not possible because larger valve sizes may have higher stresses and Chandran and colleagues studied a 23-mm bioprosthesis. However, these studies suggest that dynamic simulations of a 26-mm Sapien valve may yield higher leaflet stresses.
Comparison with TAV Simulations
Li and Sun 18 performed quasistatic simulations to 120 mm Hg of TAVs using estimated leaflet geometry (ie, 22-mm leaflet diameter) and varying thickness of porcine and bovine pericardium. Maximum principal stress was 915.62 kPa for bovine and 1565.80 kPa for porcine pericardial leaflets at the fully loaded position. Thinner leaflets resulted in higher stresses and peak stresses occurred along the leaflet-stent attachment along the commissures. Another study, by Abasi and colleagues, 25 reported maximum principal stress of 2.52 MPa of a 23-mm homemade TAV. None of the above studies included a fully assembled TAV with leaflets, stent, polyethylene terephthalate, and sutures as in our study. Our study shows greater leaflet stresses than previously reported peak stresses, and those differences may reflect our larger TAV diameter, incorporation of stent and polyethylene terephthalate to reflect interactive constraints on leaflets, and exact leaflet geometry and thickness.
Several studies have examined the Sapien TAVR in patientspecific simulations, 20,21 using computed tomography images for geometry. They investigated biomechanical interactions of TAV stents with the surrounding calcified aortic valve and root to determine risk of coronary obstruction, paravalvular leak, and aortic root rupture. They typically ignored TAV leaflets in simulation and none reported leaflet stresses. Morganti and colleagues 21 performed 26-mm Sapien XT TAVR simulations in 2 patients and examined stresses in the aortic root to estimate risk of rupture. They did demonstrate evidence of leaflet asymmetry based on patient-specific anatomy, but did not report the influence of asymmetry on TAV leaflet stresses. Sun and colleagues 14 investigated the influence of TAVR deployment asymmetry on leaflet stresses in a generic 23-mm TAV. They found peak leaflet stresses increased by 58.6% and 143.2% depending on the orientation of ellipticity. Maximum principal stresses increased from a baseline of $ 900 kPa for complete leaflet symmetry to 1.1 to 2.2 MPa depending on degree of eccentricity and orientation of ellipticity. Our baseline TAV stresses with leaflet symmetry was higher than their results due to our valve size and use of precise leaflet geometry and thickness. For noncylindrical distorted geometry, peak first principal stress increased 16% in our model deployed asymmetrically, which fell within the incremental range of the previous study.
14 Clinical studies of Sapien valves did not reveal the extremes of ellipticity demonstrated in the study by Sun and colleagues. 14 
Study Limitations
Our study did not take into account the crimping and ballooning processes that occur during TAVR. Studies have demonstrated that the crimping process physically damages TAV leaflets and may weaken leaflets and increase leaflet stress. 26 We did not destroy our TAV to test its leaflets for exact material properties given the rarity of obtaining TAVs and need for future TAV experimental in vitro tests, which are beyond the scope of this study. We used excised leaflets from surgical bioprostheses to determine the material properties of TAV leaflets. Although treatment processes for both Edwards valves are expected to be the same, thinner pericardial leaflets used in TAVRs may have different material properties 18 than were represented here. Because stent and leaflet stresses cannot be directly measured, our analyses of stress cannot be experimentally validated. Determinations of strain experimentally are beyond the scope of this work and will be considered for future studies. Complex fluid-structure interaction simulations were not incorporated and are beyond the scope of this study. Geometry used in this work was based on a single 26-mm Sapien valve. The manufacturing process can introduce geometrical variations. Their influence on the stress results was not investigated in this study. We used averaged material properties and pressure loading conditions for stress analysis and the results should be considered as the averaged or representative stress results. Lastly, the current study does not include simulation of a surgical aortic valve replacement of the same size but rather compared our results with a previous study, which may not correlate exactly for quantitative comparisons.
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CONCLUSIONS
We determined TAV stent and leaflet stresses on a 26-mm Sapien valve using exact geometry. We demonstrated that maximum stresses occurred at the stent proximally in the annulus where leaflets were attached, and at leaflet commissures where they attached to the stent. These leaflet regions will likely be areas where degeneration initiates. Future comparisons with surgical bioprostheses of comparable size will be necessary to compare relative durability based on valve design.
